Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,007
datasets available to search
ShareScore release 0.9.0
Dataset results
1,007 results for “single use”
scCoBench: Benchmarking single cell RNA-seq co-expression using promoter-reporter lines
GEO Series GSE295703. Arabidopsis thaliana. 4 samples. Type: Expression profiling by high throughput sequencing.
spaTransfer: transfer learning for single-cell and spatial transcriptomics data using non-negative matrix factorization [DG]
GEO Series GSE317381. Homo sapiens. 4 samples. Type: Other.
Single embryo RNA-seq of control and hydroxyurea treated embryos produced by nuclear transfer of cumulus cells. Single cell RNAseq of cumulus cells was performed using the same protocol.
GEO Series GSE166338. Mus musculus. 29 samples. Type: Expression profiling by high throughput sequencing.
Resolving transcriptional states and predicting lineages in the annelid Capitella teleta using single-cell RNAseq
GEO Series GSE159564. Capitella teleta. 2 samples. Type: Expression profiling by high throughput sequencing.
Dissecting gonadal cell lineage specification and sex determination during human development using a single-cell transcriptomics approach
GEO Series GSE161421. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
Single-cell full-length RNA-sequencing of MCF7 and BT-474 cells using down-scaled Smart-seq2
GEO Series GSE201443. Homo sapiens. 192 samples. Type: Expression profiling by high throughput sequencing.
The human transcription factor occupancy landscape viewed using high-resolution in situ base-conversion strand-specific single-molecule chromatin accessibility mapping
GEO Series GSE301497. Homo sapiens. 8 samples. Type: Other.
Adverse Health Effects of Cylindrospermopsin in Laboratory Animal (Mouse) Studies in Single Day Study using Affymetrix Array
GEO Series GSE83199. Mus musculus. 20 samples. Type: Expression profiling by array.
Characterization of premature cell senescence in Alzheimer’s disease using single nuclear transcriptomics
GEO Series GSE264648. Homo sapiens. 49 samples. Type: Expression profiling by high throughput sequencing.
Combination testing using a single MSH5 variant alongside HLA haplotypes improves coeliac disease risk prediction in the Polish population
GEO Series GSE65424. Homo sapiens. 15 samples. Type: SNP genotyping by SNP array.
S100A8/S100A9–toll-like receptor 4 signaling identified using single-cell RNA sequencing in ST36 acupoint mediating acupuncture analgesia
GEO Series GSE275032. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Cellular atlas of the human ovary using morphologically guided spatial transciptomics and single-cell sequencing [NanoString GeoMx]
GEO Series GSE260686. Homo sapiens. 259 samples. Type: Other.
Phage-Based Profiling of Rare Single Cells Using Nanoparticle-Directed Capture
GEO Series GSE185411. Escherichia phage M13. 11 samples. Type: Other.
Gene expression profiles of E11.5 metanephric mesenchyme and Adult Juxtaglomerular Complex cells or renal cortex from the kidneys of Crym-GFP or Ren1c-YFP transgenic mice using FACS or single-cell iso
GEO Series GSE42713. Mus musculus. 15 samples. Type: Expression profiling by array.
Mapping Human Transient Transcriptomes Using Single Nucleotide Resolution 4sU Sequencing (SNU-Seq)
GEO Series GSE179306. Homo sapiens. 10 samples. Type: Expression profiling by high throughput sequencing.
Comparative analysis of peripheral blood immunoinflammatory landscapes in patients with acute cholangitis and its secondary septic shock using single-cell RNA sequencing
GEO Series GSE229173. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Delineating pediatric brain tumor progression using single-nuclei sequencing
For more information, including a more complete description, data generator contact information, and reference, please see: https://scpca.alexslemonade.org/projects/SCPCP000010.
Supplementary information for "Ultrasonic single beam manipulation of particles and organoids through a petri-dish and a plastic tube using an acoustic field live-visualisation method"
<p>Test</p>
Dataset related to the article "Cryoballoon atrial fibrillation ablation: Single-center safety and efficacy data using a novel cryoballoon technology compared to a historical balloon platform".
<p>This record contains raw data related to the article "Cryoballoon atrial fibrillation ablation: Single-center safety and efficacy data using a novel cryoballoon technology compared to a historical balloon platform".</p> <p> </p> <p><em><strong>Abstract</strong></em></p> <p><strong>Introduction: </strong>Catheter ablation is superior to drugs regarding atrial fibrillation (AF) recurrence, symptoms improvement, and mortality reduction in heart failure. POLARx™ is a novel cryoballoon, with technical improvements seeking to improve outcomes. So far, its clinical evidence is restricted to a case report.</p> <p><strong>Methods: </strong>To compare the POLARx™ cryoballoon procedural safety and efficacy to the already established Arctic Front Advance PRO™ (AFAP) in a single-center cohort study, consecutive patients undergoing AF cryoablation with the POLARx™ were enrolled. Data were prospectively gathered. POLARx™ patients were compared with a historical cohort of patients submitted to AF cryoablation with the AFAP.</p> <p><strong>Results: </strong>Seventy patients were analyzed, 20 in POLARx™, and 50 in the AFAP group. They all underwent first-time pulmonary vein isolation, 77% were male, 94% had paroxysmal AF, median age was 62.5 years, median CHA<sub>2</sub> DS<sub>2</sub> -VASc 1, left-atrium size 34 ml/m², and 65% were receiving anticoagulation. The primary end-point, all pulmonary veins isolation, was 100% in both groups. The complication rate was similar (0% POLARx™ vs. 5.7% AFAP, p = .39). The median total procedural time was longer in the POLARx™ group (90 min vs. 60 min, p < .001), but the overall time-to-isolation (TTI; 44.8 s vs. 39 s, p = .253) and ablation time (15 min vs. 13.7 min, p = .122) was similar between POLARx™ and AFAP groups, respectively. Despite equal TTI, the POLARx™ had a lower minimal temperature reached (-57°C vs -47°C, p < .001).</p> <p><strong>Conclusion: </strong>The novel POLARx™ cryoballoon had similar efficacy and safety compared with the AFAP. It was also associated with longer procedural times, similar TTI, and lower minimum temperature reached.</p>
A Comparative Analysis of Shoes Designed for Subjects with Obesity Using a Single Inertial Sensor: Preliminary Results
<p>Walking remains a highly recommended form of exercise for the management of obesity. Thus, comfortable and adequate shoes represent, together with the prescription of a safe adapted physical activity, an important means to achieve the recommended physical activity target volume. However, the literature on shoes specific for obese individuals is inadequate. The aim of the present study was to compare the performance of shoes specifically designed for subjects with obesity with everyday sneakers during instrumented 6-min walking test and outdoor 30-min ambulation in a group of subjects with obesity using a single wearable device. Twenty-three obese individuals (mean age 58.96 years) were recruited and classified into two groups: deconditioned (n = 13) and non-deconditioned patients (n = 10). Each participant was evaluated with his/her daily sneakers and the day after with shoes specifically designed for people with obesity by means of a questionnaire related to the comfort related to each model of shoes and instrumentally during the i6MWT and an outdoor walking test. The results showed that the specifically designed shoes displayed the higher score as for comfort, in particular in the deconditioned group. During the i6MWT, the distance walked, and step length significantly increased in the deconditioned group when specifically designed shoes were worn; no significant changes were observed in the non-deconditioned individuals. The deconditioned group displayed longer step length during the outdoor 30-min ambulation test. In the non-deconditioned group, the use of specific shoes correlated to better performance in terms of gait speed and cadence. These data, although preliminary, seem to support the hypothesis that shoes specifically conceived and designed for counteracting some of the known functional limitations in subjects with obesity allow for a smoother, more stable and possibly less fatiguing gait schema over time.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.